News

BÜHLMANN has a long and very successful history in the neuroimmunology field, specifically by offering unique high quality diagnostic tests for peripheral neuropathies. Learn more about the history of clinically relevant anti-ganglioside antibodies and the development of IVD ELISA tests for neuropathies by BÜHLMANN.

BÜHLMANN is pleased to announce the addition of Quantum Blue^® Anti-Infliximab (CE IVD) to the therapeutic drug monitoring rapid test portfolio.

We had the opportunity to talk to Prof. Dr. Ulrich Sack, Head of the Immune Diagnostics, Institute of Immunology, University Hospital Leipzig about the introduction of the External Quality Assessment (EQA) scheme for the Basophil Activation Test (BAT) in the field of allergy.

We are pleased to announce that the upgraded version of the Allplex™2019-nCoV Assay from Seegene is now available.